Found: 96
Select item for more details and to access through your institution.
Using a prognostic medical device for early identification of pressure ulcers: protocol for study design.
- Published in:
- British Journal of Nursing, 2024, v. 33, n. 12, p. S8, doi. 10.12968/bjon.2024.0158
- By:
- Publication type:
- Article
Correction: Medicines and Healthcare products Regulatory Agency's "Consultation on proposals for legislative changes for clinical trials": a response from the Trials Methodology Research Partnership Adaptive Designs Working Group, with a focus on data sharing
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Medicines and Healthcare products Regulatory Agency's "Consultation on proposals for legislative changes for clinical trials": a response from the Trials Methodology Research Partnership Adaptive Designs Working Group, with a focus on data sharing.
- Published in:
- Trials, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s13063-023-07763-6
- By:
- Publication type:
- Article
Bayesian sample size determination in basket trials borrowing information between subsets.
- Published in:
- Biostatistics, 2023, v. 24, n. 4, p. 1000, doi. 10.1093/biostatistics/kxac033
- By:
- Publication type:
- Article
Bayesian borrowing for basket trials with longitudinal outcomes.
- Published in:
- Statistics in Medicine, 2023, v. 42, n. 16, p. 2819, doi. 10.1002/sim.9751
- By:
- Publication type:
- Article
Online error rate control for platform trials.
- Published in:
- Statistics in Medicine, 2023, v. 42, n. 14, p. 2475, doi. 10.1002/sim.9733
- By:
- Publication type:
- Article
Bayesian sample size determination using commensurate priors to leverage preexperimental data.
- Published in:
- Biometrics, 2023, v. 79, n. 2, p. 669, doi. 10.1111/biom.13649
- By:
- Publication type:
- Article
Developing a predictive signature for two trial endpoints using the cross-validated risk scores method.
- Published in:
- Biostatistics, 2023, v. 24, n. 2, p. 327, doi. 10.1093/biostatistics/kxaa055
- By:
- Publication type:
- Article
A randomised study of rituximab and belimumab sequential therapy in PR3 ANCA-associated vasculitis (COMBIVAS): design of the study protocol.
- Published in:
- Trials, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s13063-023-07218-y
- By:
- Publication type:
- Article
Discussion on "Adaptive enrichment designs with a continuous biomarker" by Nigel Stallard.
- Published in:
- Biometrics, 2023, v. 79, n. 1, p. 23, doi. 10.1111/biom.13643
- By:
- Publication type:
- Article
A hybrid approach to comparing parallel-group and stepped-wedge cluster-randomized trials with a continuous primary outcome when there is uncertainty in the intra-cluster correlation.
- Published in:
- Clinical Trials, 2023, v. 20, n. 1, p. 59, doi. 10.1177/17407745221123507
- By:
- Publication type:
- Article
Point estimation following a two-stage group sequential trial.
- Published in:
- Statistical Methods in Medical Research, 2023, v. 32, n. 2, p. 287, doi. 10.1177/09622802221137745
- By:
- Publication type:
- Article
Bayesian modelling strategies for borrowing of information in randomised basket trials.
- Published in:
- Journal of the Royal Statistical Society: Series C (Applied Statistics), 2022, v. 71, n. 5, p. 2014, doi. 10.1111/rssc.12602
- By:
- Publication type:
- Article
role of comorbidities alongside patient and disease characteristics in long-term disease activity in RA using UK inception cohort data.
- Published in:
- Rheumatology, 2022, v. 61, n. 11, p. 4297, doi. 10.1093/rheumatology/keac139
- By:
- Publication type:
- Article
Practical guidance for planning resources required to support publicly-funded adaptive clinical trials.
- Published in:
- BMC Medicine, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12916-022-02445-7
- By:
- Publication type:
- Article
Sample size estimation using a latent variable model for mixed outcome co‐primary, multiple primary and composite endpoints.
- Published in:
- Statistics in Medicine, 2022, v. 41, n. 13, p. 2303, doi. 10.1002/sim.9356
- By:
- Publication type:
- Article
Capturing the real‐world benefit of residual β‐cell function during clinically important time‐periods in established Type 1 diabetes.
- Published in:
- Diabetic Medicine, 2022, v. 39, n. 5, p. 1, doi. 10.1111/dme.14814
- By:
- Publication type:
- Article
Predictors of poor function in RA based on two prospective UK inception cohorts. Do comorbidities matter?
- Published in:
- Rheumatology, 2022, v. 61, n. 4, p. 1563, doi. 10.1093/rheumatology/keab598
- By:
- Publication type:
- Article
Response adaptive intervention allocation in stepped‐wedge cluster randomized trials.
- Published in:
- Statistics in Medicine, 2022, v. 41, n. 6, p. 1081, doi. 10.1002/sim.9317
- By:
- Publication type:
- Article
Two‐stage penalized regression screening to detect biomarker–treatment interactions in randomized clinical trials.
- Published in:
- Biometrics, 2022, v. 78, n. 1, p. 141, doi. 10.1111/biom.13424
- By:
- Publication type:
- Article
Conditional power and friends: The why and how of (un)planned, unblinded sample size recalculations in confirmatory trials.
- Published in:
- Statistics in Medicine, 2022, v. 41, n. 5, p. 877, doi. 10.1002/sim.9288
- By:
- Publication type:
- Article
Advantages of multi-arm non-randomised sequentially allocated cohort designs for Phase II oncology trials.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Improving power in PSA response analyses of metastatic castration-resistant prostate cancer trials.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Borrowing of information across patient subgroups in a basket trial based on distributional discrepancy.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A two‐stage drop‐the‐losers design for time‐to‐event outcome using a historical control arm.
- Published in:
- Pharmaceutical Statistics, 2022, v. 21, n. 1, p. 268, doi. 10.1002/pst.2168
- By:
- Publication type:
- Article
Increasing power in the analysis of responder endpoints in rheumatology: a software tutorial.
- Published in:
- BMC Rheumatology, 2021, v. 5, n. 1, p. 1, doi. 10.1186/s41927-021-00224-0
- By:
- Publication type:
- Article
Treatment allocation strategies for umbrella trials in the presence of multiple biomarkers: A comparison of methods.
- Published in:
- Pharmaceutical Statistics, 2021, v. 20, n. 6, p. 990, doi. 10.1002/pst.2119
- By:
- Publication type:
- Article
Revisiting the JOQUER trial: stratification of primary Sjögren's syndrome and the clinical and interferon response to hydroxychloroquine.
- Published in:
- Rheumatology International, 2021, v. 41, n. 9, p. 1593, doi. 10.1007/s00296-021-04927-y
- By:
- Publication type:
- Article
Innovative trial approaches in immune-mediated inflammatory diseases: current use and future potential.
- Published in:
- BMC Rheumatology, 2021, v. 5, n. 1, p. 1, doi. 10.1186/s41927-021-00192-5
- By:
- Publication type:
- Article
Bayesian design and analysis of external pilot trials for complex interventions.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS) for hospitalised patients with mild or moderate COVID-19 pneumonia: a structured summary of a study protocol for a randomised controlled trial.
- Published in:
- 2021
- By:
- Publication type:
- letter
Statistical consideration when adding new arms to ongoing clinical trials: the potentials and the caveats.
- Published in:
- 2021
- By:
- Publication type:
- letter
Employing a latent variable framework to improve efficiency in composite endpoint analysis.
- Published in:
- Statistical Methods in Medical Research, 2021, v. 30, n. 3, p. 702, doi. 10.1177/0962280220970986
- By:
- Publication type:
- Article
Controlling type I error rates in multi‐arm clinical trials: A case for the false discovery rate.
- Published in:
- Pharmaceutical Statistics, 2021, v. 20, n. 1, p. 109, doi. 10.1002/pst.2059
- By:
- Publication type:
- Article
Mentalization for Offending Adult Males (MOAM): study protocol for a randomized controlled trial to evaluate mentalization-based treatment for antisocial personality disorder in male offenders on community probation.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Developing and testing high‐efficacy patient subgroups within a clinical trial using risk scores.
- Published in:
- Statistics in Medicine, 2020, v. 39, n. 24, p. 3285, doi. 10.1002/sim.8665
- By:
- Publication type:
- Article
Graphical approaches for the control of generalized error rates.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Developing a roadmap to improve trial delivery for under-served groups: results from a UK multi-stakeholder process.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Including non-concurrent control patients in the analysis of platform trials: is it worth it?
- Published in:
- 2020
- By:
- Publication type:
- journal article
The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Analysis of responder-based endpoints: improving power through utilising continuous components.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Prevalence of Multiplicity and Appropriate Adjustments Among Cardiovascular Randomized Clinical Trials Published in Major Medical Journals.
- Published in:
- JAMA Network Open, 2020, p. e203082, doi. 10.1001/jamanetworkopen.2020.3082
- By:
- Publication type:
- Article
Developing a composite outcome measure for frailty prevention trials - rationale, derivation and sample size comparison with other candidate measures.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A web application for the design of multi-arm clinical trials.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A latent variable model for improving inference in trials assessing the effect of dose on toxicity and composite efficacy endpoints.
- Published in:
- 2020
- By:
- Publication type:
- journal article
To add or not to add a new treatment arm to a multiarm study: A decision-theoretic framework.
- Published in:
- 2019
- By:
- Publication type:
- journal article
When to keep it simple - adaptive designs are not always useful.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Admissible multiarm stepped-wedge cluster randomized trial designs.
- Published in:
- 2019
- By:
- Publication type:
- journal article
029. PR3-ANCA Status Following Rituximab: A Useful Biomarker for Relapse Prediction in Anca-Associated Vasculitis.
- Published in:
- 2019
- By:
- Publication type:
- Abstract
322. A randomised, double-blind, controlled, mechanistic study of rituximab and belimumab combination therapy in PR3 ANCA-associated vasculitis (combivas): study protocol.
- Published in:
- 2019
- By:
- Publication type:
- Abstract